Advertisement
Screener

CHAMPIONS ONCOLOGY, INC. (CSBR) Graph

CSBR Revenue Flow

Filed revenue amounts for 2026-05-01 to 2026-07-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-07-31: Revenue $15.23M; Revenue including tax (m); Cost of revenue $7.53M; Research and development $2.34M.
  • 2026-04-30: Revenue $13.84M*; Revenue including tax (m); Cost of revenue $6.81M*; Research and development $2.12M*.
  • 2026-01-31: Revenue $16.56M; Revenue including tax (m); Cost of revenue $8.83M; Research and development $2.27M.
  • 2025-10-31: Revenue $15.04M; Revenue including tax (m); Cost of revenue $7.26M; Research and development $2.62M.

Counterparty Name

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CSBR revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Operating Subsidiaries$0.00Revenue$15.23MCost of revenue$7.53MOperating income-$409.00KOther income, net-$6.00KResearch & development$2.34MPre-tax income-$415.00KIncome tax$11.00KNet income-$426.00K

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CSBR revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Pharmacology Services$14.16MTranslational OncologySolutions TOS License Revenue$893.00KProduct AndService Other$183.00KRevenue$15.23MCost of revenue$7.53MOperating income-$409.00KOther income, net-$6.00KResearch & development$2.34MPre-tax income-$415.00KIncome tax$11.00KNet income-$426.00K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-07-31$15.23M(m)$7.53M$2.34M(m)$11.00K-$426.00K
2026-04-30$13.84M*(m)$6.81M*$2.12M*(m)$172.00K*$506.82K*
2026-01-31$16.56M(m)$8.83M$2.27M(m)$42.00K-$279.00K
2025-10-31$15.04M(m)$7.26M$2.62M(m)$18.00K$268.00K
2025-07-31$13.99M(m)$8.00M$2.08M(m)$14.00K-$466.00K
2025-01-31$17.04M(m)$6.62M$1.72M(m)$23.00K$4.50M
2024-10-31$13.49M(m)$7.43M$1.69M(m)$11.00K$728.00K
2024-07-31$14.06M(m)$7.07M$1.45M(m)$21.00K$1.31M
2024-01-31$12.02M(m)$7.85M$2.19M(m)$11.00K-$2.53M
2023-10-31$11.57M(m)$6.62M$2.52M(m)$11.00K-$2.07M
2023-07-31$12.56M(m)$7.68M$2.79M(m)$28.00K-$2.57M
2023-01-31$12.77M(m)$7.70M$3.20M(m)$17.00K-$2.44M
2022-10-31$14.28M(m)$7.44M$2.60M(m)$14.00K-$16.00K
2022-07-31$13.74M(m)$7.05M$2.89M(m)$17.00K-$319.00K
2022-01-31$13.19M(m)$6.41M$2.18M(m)$11.00K$787.00K
2021-10-31$11.79M(m)$5.61M$2.30M(m)$12.00K$277.00K
2021-07-31$11.25M(m)$5.40M$2.30M(m)$14.00K-$172.00K
2021-01-31$10.81M(m)$4.62M$1.88M(m)$15.00K$959.00K
2020-10-31$10.12M(m)$5.64M$1.65M(m)$15.00K$1.00K
2020-07-31$9.55M(m)$5.34M$1.60M(m)$13.00K$75.00K
2020-04-30(m)(m)(m)(m)$10.66M*(m)(m)
2020-01-31$9.01M(m)$4.33M$1.39M$8.58M$12.00K$75.00K
2019-10-31$7.63M$7.63M$3.88M$1.34M$7.33M$11.00K$307.00K
2019-07-31$6.74M$6.74M$3.75M$1.30M$7.35M$15.00K-$641.00K
2019-01-31$6.43M$6.43M$3.43M$1.27M$6.80M$0.00-$369.00K
2018-10-31(m)$6.69M$3.45M$1.19M$6.42M$1.00K$267.00K
2018-07-31$6.22M$6.22M$3.08M$1.09M$5.74M$0.00$483.00K
2018-01-31(m)$5.08M$2.47M$1.04M$5.15M$2.00K-$76.00K
2017-10-31(m)$5.20M$2.65M$1.11M$5.27M$11.00K-$94.00K
2017-07-31$5.03M$5.03M$2.64M$1.12M$5.65M$4.00K-$674.00K
2017-01-31(m)(m)(m)$998.00K$4.97M$0.00-$1.41M
2016-10-31(m)(m)(m)$1.01M$4.95M-$5.00K-$504.00K
2016-07-31(m)(m)(m)$1.21M$6.19M$14.00K-$2.55M
2016-01-31(m)(m)(m)$999.00K$4.92M$31.00K-$2.41M
2015-10-31(m)(m)(m)$919.00K$5.46M$41.00K-$2.55M
2015-07-31(m)(m)(m)$1.10M$5.72M$6.00K-$2.91M
2015-01-31(m)(m)(m)$1.09M$5.25M$12.00K-$2.82M
2014-10-31(m)(m)(m)$1.25M$5.55M$10.00K-$3.08M
2014-07-31(m)(m)(m)$1.42M$5.64M$5.00K-$3.55M
2014-01-31(m)(m)(m)$535.00K$5.10M$5.00K-$574.00K
2013-10-31(m)(m)(m)$677.00K$4.08M$3.00K-$2.32M
2013-07-31(m)(m)(m)$402.00K$3.79M$3.00K-$2.23M
2013-01-31(m)(m)(m)$592.00K$3.64M$5.00K-$990.00K
2012-10-31(m)(m)(m)$436.00K$3.37M$1.00K-$1.97M
2012-07-31(m)(m)(m)$387.00K$3.71M$3.00K-$1.32M
2012-01-31(m)(m)(m)$930.00K$4.17M$0.00-$1.72M
2011-10-31(m)(m)(m)$1.01M$4.21M$0.00-$2.35M
2011-07-31(m)(m)(m)$541.00K$3.85M$0.00-$2.04M
2011-01-31(m)(m)(m)$434.00K$3.59M$0.00-$415.00K
2010-10-31(m)(m)(m)$673.00K$1.95M$0.00-$54.00K
2010-07-31(m)(m)(m)$919.00K$2.20M$0.00-$591.00K

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-10-31$29.03M(m)$15.26M$4.70M(m)$33.00K-$169.00K
2024-10-31$27.55M(m)$14.50M$3.14M(m)$31.00K$2.04M
2023-10-31$24.13M(m)$14.30M$5.31M(m)$39.00K-$4.64M
2022-10-31$28.03M(m)$14.49M$5.49M(m)$31.00K-$335.00K
2021-10-31$23.04M(m)$11.01M$4.60M(m)$26.00K$105.00K
2020-10-31$19.66M(m)$10.98M$3.25M(m)$28.00K$76.00K
2019-10-31$14.36M$14.36M$7.63M$2.64M$14.69M$26.00K-$334.00K
2018-10-31(m)$12.92M$6.53M$2.28M$12.16M$1.00K$750.00K
2017-10-31(m)$10.24M$5.29M$2.23M$10.93M$15.00K-$768.00K
2016-10-31(m)(m)(m)$2.22M$11.14M$9.00K-$3.05M
2015-10-31(m)(m)(m)$2.02M$11.18M$47.00K-$5.46M
2014-10-31(m)(m)(m)$2.66M$11.18M$15.00K-$6.68M
2013-10-31(m)(m)(m)$1.08M$7.88M$6.00K-$4.56M
2012-10-31(m)(m)(m)$823.00K$7.08M$4.00K-$3.30M
2011-10-31(m)(m)(m)$1.62M$8.06M$0.00-$4.39M
2010-10-31(m)(m)(m)$1.50M$4.14M$0.00-$645.00K

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-01-31$45.59M(m)$24.09M$6.97M(m)$74.00K-$508.00K
2025-01-31$44.59M(m)$21.12M$4.86M(m)$54.00K$6.54M
2024-01-31$36.15M(m)$22.15M$7.49M(m)$49.00K-$7.17M
2023-01-31$40.80M(m)$22.19M$8.69M(m)$48.00K-$2.77M
2022-01-31$36.23M(m)$17.41M$6.78M(m)$37.00K$892.00K
2021-01-31$30.48M(m)$15.60M$5.13M(m)$43.00K$1.03M
2020-01-31$23.38M(m)$11.96M$4.04M$23.27M$38.00K$72.00K
2019-01-31$19.35M$19.35M$9.96M$3.55M$18.96M$0.00$381.00K
2018-01-31(m)$15.32M$7.74M$3.31M$16.07M$18.00K-$844.00K
2017-01-31(m)(m)(m)$3.22M$16.11M$7.00K-$4.46M
2016-01-31(m)(m)(m)$3.02M$16.11M$76.00K-$7.87M
2015-01-31(m)(m)(m)$3.76M$16.46M$27.00K-$9.46M
2014-01-31(m)(m)(m)$1.61M$12.97M$13.00K-$5.13M
2013-01-31(m)(m)(m)$1.42M$10.72M$6.00K-$4.28M
2012-01-31(m)(m)(m)$2.56M$12.23M$0.00-$6.11M
2011-01-31(m)(m)(m)$2.12M$7.73M$0.00-$1.06M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-04-30$59.42M$30.90M$9.08M(m)$246.00K-$1.18K
2025-04-30$56.94M$28.39M$6.83M(m)-$75.00K$4.70K
2024-04-30$50.16M$29.40M$9.54M(m)-$32.00K-$7.28K
2023-04-30$53.87M$29.53M$11.54M(m)$68.00K-$5.33M
2022-04-30$49.11M$23.63M$9.37M(m)$35.00K$548.00K
2021-04-30$41.04M$21.45M$7.20M(m)$75.00K$362.00K
2020-04-30$32.12M$17.00M$5.85M$33.93M$130.00K-$2.09M
2019-04-30(m)(m)$4.80M$26.80M$103.00K$128.00K
2018-04-30$20.24M(m)$4.40M$21.59M$33.00K-$1.48M
2017-04-30(m)(m)$4.29M$22.22M$19.00K-$6.88M
2016-04-30(m)(m)$4.19M$21.50M$92.00K-$10.45M
2015-04-30(m)(m)$4.84M$22.10M$127.00K-$13.14M
2014-04-30(m)(m)$2.27M$17.81M$17.00K-$7.41M
2013-04-30(m)(m)$1.92M$14.54M$10.00K-$6.33M
2012-04-30(m)(m)$2.94M$16.21M-$2.00K-$8.66M
2011-04-30(m)(m)$2.91M$12.12M$11.00K-$3.80M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioStem Technologies, Inc. (BSEM)United States$0.069B
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Vaxart, Inc. (VXRT)United States$0.080B3.84
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48